Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Php314 - The Rise of Nice Advice on the Use of Pharmaceuticals, Medical Devices and Digital Health Care in the NHS

Value in Health

English

Ds3 - Regorafenib in Metastatic Colorectal Cancer: Cost-Effectiveness Analysis Based on Propensity Score Weighted Cohort of Czech Registry

English

Pdb22 - Clinical and Demographic Characteristics of Patients Reaching a High Daily Dose of Ideglira Six Months After Initiation in a Real-World Setting

English

Pmu77 - Analysis of Decisions of Patients Not to Purchase Prescription Medicines. Results of the Cross-Sectional Pharmacy-Based Survey Conducted in Poland

English

Pdb44 - The Health Economic Value of Short-Term Cardiovascular Benefits Associated With SGLT-2i From CVD-Real

English

Php33 - Understanding the Japanese Policy Initiatives and the Patient Characteristics of Rare, Intractable Diseases

English

Php35 - Amnog Early Benefit Assessment (Eba) and Market Penetration of New Drugs for Melanoma, Multiple Sclerosis and Diabetes Mellitus in Germany

English

Pnd57 - The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy

English

Pss24 - Estimation of the Long-Term Population Costs and Benefits for Five Different Varicella Childhood Immunization Strategies in Bulgaria

English

Pcn232 - Variation in Access to Pd-1 Immunotherapies in Europe

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Health Policy

Php314 - The Rise of Nice Advice on the Use of Pharmaceuticals, Medical Devices and Digital Health Care in the NHS

Ds3 - Regorafenib in Metastatic Colorectal Cancer: Cost-Effectiveness Analysis Based on Propensity Score Weighted Cohort of Czech Registry

Pdb22 - Clinical and Demographic Characteristics of Patients Reaching a High Daily Dose of Ideglira Six Months After Initiation in a Real-World Setting

Pmu77 - Analysis of Decisions of Patients Not to Purchase Prescription Medicines. Results of the Cross-Sectional Pharmacy-Based Survey Conducted in Poland

Pdb44 - The Health Economic Value of Short-Term Cardiovascular Benefits Associated With SGLT-2i From CVD-Real

Php33 - Understanding the Japanese Policy Initiatives and the Patient Characteristics of Rare, Intractable Diseases

Php35 - Amnog Early Benefit Assessment (Eba) and Market Penetration of New Drugs for Melanoma, Multiple Sclerosis and Diabetes Mellitus in Germany

Pnd57 - The Cost-Effectiveness of Alemtuzumab in the Management of Relapse-Remitting Multiple Sclerosis in Italy

Pss24 - Estimation of the Long-Term Population Costs and Benefits for Five Different Varicella Childhood Immunization Strategies in Bulgaria

Pcn232 - Variation in Access to Pd-1 Immunotherapies in Europe